Viridian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 08, 2023 at 09:31 pm
Viridian Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 55.06 million compared to USD 29.49 million a year ago. Basic loss per share from continuing operations was USD 1.27 compared to USD 1.06 a year ago.
For the six months, net loss was USD 123.21 million compared to USD 55.18 million a year ago. Basic loss per share from continuing operations was USD 2.88 compared to USD 2.05 a year ago.